Meridian Bioscience Customer Care Center

News Release Search

07/20/10	Meridian Bioscience Reports Third Quarter and Nine Months Operating Results, Declares Regular Cash Dividend, and Updates Fiscal 2010 Guidance
07/20/10	Meridian Bioscience Acquires Leading Manufacturer and Distributor of Molecular Reagents
07/13/10	Meridian Bioscience Receives FDA Clearance for New illumigene(TM) Molecular Platform
07/07/10	Meridian Bioscience, Inc. Enters into Product Development and Distribution Agreement with DiaSorin S.p.A.
04/20/10	Meridian Bioscience Reports Second Quarter and Six Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2010 Guidance
03/22/10	Meridian Bioscience Submits New illumigene(TM) Molecular C. difficile Test to U.S. FDA for Marketing Clearance
03/17/10	Meridian Bioscience Revises Guidance for Fiscal 2010 and Comments on Preliminary Second Quarter Operating Results and Business Outlook Including illumigene(TM) Update
01/21/10	Meridian Bioscience Reports Record First Quarter Sales and Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2010 Guidance
11/12/09	Meridian Bioscience Reports Record Fiscal 2009 Operating Results, Increases Regular Cash Dividend Rate, and Reaffirms Guidance
09/30/09	Meridian Bioscience Europe Announces Agreement to Distribute Test For GI Disease
09/17/09	Meridian Bioscience Granted Special 510(k) Clearance to Add 2009 H1N1 Influenza A Virus Analytical Sensitivity Claim to the TRU FLU(R) Test Package Insert
09/15/09	Meridian Bioscience Provides Sales and Earnings Guidance for Fiscal 2010 and Reaffirms Fiscal 2009 Guidance